Avg closing price
Price range

7 Steven Cohen Theravance Biopharma Trades

Steven Cohen's position in Theravance Biopharma is currently worth $1.07 Million. That's 0.01% of their equity portfolio (777th largest holding). The first Theravance Biopharma trade was made in Q4 2016. Since then Steven Cohen bought shares two more times and sold shares on four occasions. The investor's estimated purchase price is $1.17 Million, resulting in a loss of 8.1%.

Avg closing price
Price range
Sold 83.9% shares (-550 Thousand shares) Q2 2022
Avg closing price $9.21
Price range $8.41 - $10.34
Increased shares by 352.2% (+511 Thousand shares) Q1 2022
Avg closing price $9.80
Price range $8.33 - $12.96
Sold 95.7% shares (-3.26 Million shares) Q4 2021
Avg closing price $8.72
Price range $7.42 - $11.05
New holding (+3.41 Million shares) Q3 2021
Avg closing price $11.19
Price range $6.77 - $14.41
Sold -90.7 Thousand shares Q2 2017
Avg closing price $38.45
Price range $35.46 - $42.56
Sold 46.9% shares (-80 Thousand shares) Q1 2017
Avg closing price $31.95
Price range $28.28 - $37.06
New holding (+171 Thousand shares) Q4 2016
Avg closing price $31.02
Price range $24.57 - $38.58

News about Theravance Biopharma Inc and Steven Cohen

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!